MEDPMedpace Holdings, Inc.
Is it growing?
Growing: revenue growing +25% year on year and earnings up +27% year on year.
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +22% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 21.0% now against 21.4% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is MEDP growing?
Medpace Holdings, Inc. has grown revenue 18% a year over three years and 22% a year over five, with earnings per share compounding at 27%.
Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · compounding fast · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +22%
Revenue growth, 5-year rate · +18% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- +27%
Earnings per share, 3-year rate · revenue +18% · earnings outgrew revenue: margins or the share count worked for shareholders
- Years of annual history on file
- 11
Years of annual history on file · FY2015 to FY2025, as filed
Details›
- Revenue FY2021
- $1.14B
- Revenue FY2022
- $1.46B
- Revenue FY2023
- $1.89B
- Revenue FY2024
- $2.11B
- Revenue FY2025
- $2.53B
Annual income statements as filed with the SEC.
Diagnostics & Research
Ranks #1 of 21 by RyuScore